跳至主要内容
临床试验/NCT06665763
NCT06665763尚未招募不适用

The Lactate Project: Investigating the Impact of Lactate to Preserve Vital Organ Blood Supply and Function in Heart and Brain

University of Aarhus2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2025年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
8
试验地点
2
主要终点
Cerebral glucose uptake

研究概览

简要总结

The aim of the proposed study is to investigate the effect of increased plasma lactate concentrations on the heart and brain's metabolism of other energy sources, primarily glucose in the brain and glucose and FFA in the heart.

The investigator hypothesize that:

  • An acute increase in lactate plasma concentration will decrease cerebral glucose uptake and increase cerebral blood flow
  • An acute increase in lactate plasma concentration will decrease palmitate and glucose uptake in the myocardium, and increase myocardial perfusion

详细描述

SCREENING VISIT

During the initial screening visit, the investigators will inform all potential volunteers about the project, and volunteers will have the chance to ask questions about participation in the project.

The investigators will register the following data

  1. Medical history to assess exclusion criteria
  2. Weight, height, BMI
  3. Standard medical examination including pulse, blood pressure and an ECG

After assessment of inclusion- and exclusion criteria remaining volunteers will be offered to participate in the project. The investigators will screen potential volunteers with the following blood samples: haemoglobin, HbA1c, glucose, cholesterol, triglyceride, TSH, creatinine, albumin, sodium, potassium, ALAT, ASAT, bilirubin and coagulation parameters.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
55 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 55-75 years
  • •Male or postmenopausal female
  • •BMI 20-35 kg/m2
  • •Signed informed consent form

排除标准

  • •Clinically significant heart, lung, kidney, kidney, liver, endocrine or malignant disease basedon information obtained during an initial screening visit as well as blood samples and an ECG.
  • •Blood donation within the last 3 months
  • •Alcohol- or substance abuse
  • •Participation in other clinical trials involving ionized radiation within the last 6 months
  • •Claustrophobia

研究组 & 干预措施

Saline infusion (Placebo)

Placebo Comparator

干预措施: Saline infusion (placebo) (Other)

Na-Lactate infusion

Experimental

干预措施: Sodium Lactate Solution (Other)

结局指标

主要结局

Cerebral glucose uptake

时间窗: From T=300-360 (minutes)

Cerebral glucose uptake (\[18F\]FDG PET scan) under basal and hyperinsulinemic- euglycemic conditions (clamp conditions).

次要结局

  • Cerebral blood flow(T = 0-10 (minutes))
  • Myocardial perfusion(T = 0-10 (minutes))
  • Myocardial glucose uptake(T = 300-360 (minutes))
  • Myocardial FFA uptake and oxidation(T = 30-70 (minutes))
  • Myocardial contractility(T=0-10 (minutes))
  • Myocardial oxygen consumption and efficiency(T=150-180 (minutes))
  • Blood sampling(T = -60 to 360 (minutes))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验